Escalon divests vascular lines to Vascular Solutions

Escalon Medical has sold its guided-needle product lines to Vascular Solutions for about $5.8 million, plus a one-time payment of 25 percent of the net sales of the company's VascuView TAP products sold between July 1, 2010 and June 30, 2011.

"The divestiture of the Vascular Access product line was based on extensive strategic evaluation which concluded that the divestiture of these non core product lines would enable us to better focus our efforts and resources on our Ophthalmic and IVD businesses," says Richard DePiano, Jr., Escalon president.

Escalon also will receive $750,000 in cash when the manufacturing transfer is completed, a process it expects to complete within four months.

- see Escalon's press release
- check out Forbes' story

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.